199 related articles for article (PubMed ID: 25746236)
1. Abrupt decline in oxycodone-caused mortality after implementation of Florida's Prescription Drug Monitoring Program.
Delcher C; Wagenaar AC; Goldberger BA; Cook RL; Maldonado-Molina MM
Drug Alcohol Depend; 2015 May; 150():63-8. PubMed ID: 25746236
[TBL] [Abstract][Full Text] [Related]
2. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
[TBL] [Abstract][Full Text] [Related]
3. Trends in Florida's Prescription Drug Monitoring Program registration and utilization: Implications for increasing voluntary use.
Delcher C; Wang Y; Young HW; Goldberger BA; Schmidt S; Reisfield GM
J Opioid Manag; 2017; 13(5):283-289. PubMed ID: 29199394
[TBL] [Abstract][Full Text] [Related]
4. Impact of Florida's prescription drug monitoring program on drug- related fatal vehicle crashes: a difference-in-differences approach.
Tatar M; Jalali MS; Tak HJ; Chen LW; Araz OM; Wilson FA
Inj Prev; 2022 Apr; 28(2):105-109. PubMed ID: 34162702
[TBL] [Abstract][Full Text] [Related]
5. Attitudes of Florida pharmacists toward implementing a state prescription drug monitoring program for controlled substances.
Fass JA; Hardigan PC
J Manag Care Pharm; 2011; 17(6):430-8. PubMed ID: 21787028
[TBL] [Abstract][Full Text] [Related]
6. Decline in drug overdose deaths after state policy changes - Florida, 2010-2012.
Johnson H; Paulozzi L; Porucznik C; Mack K; Herter B;
MMWR Morb Mortal Wkly Rep; 2014 Jul; 63(26):569-74. PubMed ID: 24990490
[TBL] [Abstract][Full Text] [Related]
7. Impact of Florida's prescription drug monitoring program and pill mill law on high-risk patients: A comparative interrupted time series analysis.
Chang HY; Murimi I; Faul M; Rutkow L; Alexander GC
Pharmacoepidemiol Drug Saf; 2018 Apr; 27(4):422-429. PubMed ID: 29488663
[TBL] [Abstract][Full Text] [Related]
8. A description of Medical Examiner prescription-related deaths and prescription drug monitoring program data.
Lev R; Petro S; Lee O; Lucas J; Stuck A; Vilke GM; Castillo EM
Am J Emerg Med; 2016 Mar; 34(3):510-4. PubMed ID: 26778639
[TBL] [Abstract][Full Text] [Related]
9. Prescription drug monitoring program design and function: A qualitative analysis.
Rutkow L; Smith KC; Lai AY; Vernick JS; Davis CS; Alexander GC
Drug Alcohol Depend; 2017 Nov; 180():395-400. PubMed ID: 28978492
[TBL] [Abstract][Full Text] [Related]
10. Florida's Opioid Crackdown and Mortality From Drug Overdose, Motor Vehicle Crashes, and Suicide: A Bayesian Interrupted Time-Series Analysis.
Feder KA; Mojtabai R; Stuart EA; Musci R; Letourneau EJ
Am J Epidemiol; 2020 Sep; 189(9):885-893. PubMed ID: 32077469
[TBL] [Abstract][Full Text] [Related]
11. Trends in licit and illicit drug-related deaths in Florida from 2001 to 2012.
Lee D; Delcher C; Maldonado-Molina MM; Bazydlo LA; Thogmartin JR; Goldberger BA
Forensic Sci Int; 2014 Dec; 245():178-86. PubMed ID: 25447191
[TBL] [Abstract][Full Text] [Related]
12. Associations between pain clinic density and distributions of opioid pain relievers, drug-related deaths, hospitalizations, emergency department visits, and neonatal abstinence syndrome in Florida.
Sauber-Schatz EK; Mack KA; Diekman ST; Paulozzi LJ
Drug Alcohol Depend; 2013 Nov; 133(1):161-6. PubMed ID: 23769424
[TBL] [Abstract][Full Text] [Related]
13. Fatal poisonings involving propoxyphene before and after voluntary withdrawal from the United States' market: An analysis from the state of Florida.
Delcher C; Chen G; Wang Y; Slavova S; Goldberger BA
Forensic Sci Int; 2017 Nov; 280():228-232. PubMed ID: 29080523
[TBL] [Abstract][Full Text] [Related]
14. Drug overdose deaths--Florida, 2003-2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):869-72. PubMed ID: 21734633
[TBL] [Abstract][Full Text] [Related]
15. Reductions in prescription opioid diversion following recent legislative interventions in Florida.
Surratt HL; O'Grady C; Kurtz SP; Stivers Y; Cicero TJ; Dart RC; Chen M
Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):314-20. PubMed ID: 24677496
[TBL] [Abstract][Full Text] [Related]
16. Opioid Overdose Deaths and Florida's Crackdown on Pill Mills.
Kennedy-Hendricks A; Richey M; McGinty EE; Stuart EA; Barry CL; Webster DW
Am J Public Health; 2016 Feb; 106(2):291-7. PubMed ID: 26691121
[TBL] [Abstract][Full Text] [Related]
17. Methadone related deaths compared to all prescription related deaths.
Lev R; Petro S; Lee A; Lee O; Lucas J; Castillo EM; Egnatios J; Vilke GM
Forensic Sci Int; 2015 Dec; 257():347-352. PubMed ID: 26513639
[TBL] [Abstract][Full Text] [Related]
18. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
Cicero TJ; Ellis MS
JAMA Psychiatry; 2015 May; 72(5):424-30. PubMed ID: 25760692
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
[TBL] [Abstract][Full Text] [Related]
20. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
